Plain-English translation of NCT06904989 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Chemotherapy can damage nerves in your feet, causing numbness, tingling, and pain that affects balance and daily life. This trial compares two approaches: standard custom shoes and insoles versus those same devices plus a specialized soft silicone sock for indoor wear. The goal is to find which option works best at relieving your symptoms and improving your quality of life.
Nerve damage in the feet is very common after chemotherapy, but there's no standard way to assess or treat it in Sweden. This trial aims to create a structured rehabilitation program and test whether the new silicone sock device can better reduce symptoms and help patients move around more comfortably.
You likely qualify if…
You likely don't qualify if…
You will be assigned to receive either standard custom shoes and insoles, or those devices plus a specialized silicone sock for wearing indoors. The research team will assess your foot symptoms and how well you can walk and balance. You'll likely have follow-up visits to check how the devices are working and whether your symptoms improve over time.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Sweden
Vastra Gotaland Region
Enrollment target
~40 participants
Started
December 2024
Primary completion
June 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Malin Rydholm, MD
Vastragotaland regionen
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.